Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Cardiology/Vascular Diseases | Hematology
 Disease Category: Blood Clots
Location: United States, NC

Trial Information

AMPLIFY- A Safety and Efficacy Trial Evaluating the Use of Apixaban in the Treatment of Symptomatic Deep Vein Thrombosis and Pulmonary Embolism

Study evaluating the effects of an investigational blood thinner, apixaban, in preventing venous thromboembolic (VTE) recurrence (the formation of presence of a blood clot) or death in patients with deep vein thrombosis (DVT) or pulmonary embolism (PE) over 6 months. The study involves taking an experimental medicine/placebo and out-patient clinic visits over the course of 6 months. The visits may include: blood draws, ECGs, physical exams, urine samples and pregnancy tests when applicable. Each visit is expected to last approximately 1 hour.

Patient Inclusion/ Exclusion Criteria:

  • Contact center for more details.

Rebecca Palermo, RN, MS, Manager, Heart & Vascular Research Department
Rex Healthcare
4420 Lake Boone Trail
Raleigh, NC 27607
Phone: 919-784-3795
Fax: 919-784-3426
Email: rebecca.palermo@rexhealth.com

View Map

Research Center Information: Rex Healthcare

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.